Avalanche Biotechnologies proposes follow-on

Avalanche Biotechnologies Inc. (NASDAQ:AAVL), Menlo Park, Calif. Business: Ophthalmic Date announced: 2014-12-18 Type: Follow-on To be raised: Up to $100 million Shares: TBD Price prior: $50.45 Underw...